Gilead Sciences Investor

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

Estimated Revenue: $1B to $10B
Funding Status: IPO
Headquarters: Foster City, California, United States
Last Funding Date: 1988-01-01
Investors Number: 39
Number Of Exists: 10
Acquisitions Number: Made Acquisitions
Founded Date: 1987-06-22
Technology: Others
Industry: Biopharma, Biotechnology, Commercial, Health Care, Manufacturing, Pharmaceutical
Last Funding Type: Seed
Employee Number: 10001+